Patrick Reville
24PUBLICATIONS
120CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Dec 10, 2025
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.Courtney D DiNardo, Wei-Ying Jen, Koichi Takahashi
|Jul 09, 2025
An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and Chemoresistance.Cuijuan Han, Zhiping Zhang, Edie I Crosse
|Jun 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML.Courtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi
|Apr 08, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis.Naval Daver, Jayastu Senapati, Hagop M Kantarjian
|Apr 03, 2025
Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes.Patrick K Reville, Bofei Wang, Jennifer Marvin-Peek
|Mar 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions.Eitan Kugler, Enes Dasdemir, Alex Bataller
Pageof 4
Frequent Collaborators
18 joint publications
Naval G Daver
17 joint publications
Courtney DiNardo
14 joint publications
Koji Sasaki
13 joint publications
Tapan M Kadia
12 joint publications
Gautam Borthakur
12 joint publications
Marina Y Konopleva
12 joint publications
Hussein A Abbas
11 joint publications
Hagop M Kantarjian
11 joint publications
Guillermo Garcia-Manero
11 joint publications
Nicholas Short
